Skip to content

Leading the Way in Revolutionary
Cannabinoid Medicines

Safe and Effective, Breakthrough
Treatments

Our vision is to leverage the untapped potential of cannabinoids in a systematic and clinically validated manner.

Our innovative formulations are built on specific isolated cannabinoids in precise ratios and are put through the full rigour of clinical trials to establish safety and effectiveness.

What We Do

Sanna Sleep

Our active focus is on sleep, and the Sanna Sleep formulation represents the world’s first cannabinoid sleep capsule with successful clinical results.

With roughly 2 in 3 of adults reporting that they do not get enough quality sleep, and 1/3 adults in the UK suffering with insomnia, the health, safety and productivity costs of sleep are enormous.

Despite the prevalence of these issues, there exists a significant treatment gap between problematic options like prescription benzodiazepines on one side and largely ineffective natural remedies with no clinical support on the other. Sanna Sleep bridges that gap.

The Right Partners

With its strong commitment to research-driven innovation in the pharmacological space and deep expertise in issues around sleep, King’s College London is a perfect fit to partner with Sanna Science.

Principal and contributing investigators from King’s College London will run the Phase 1b and PK clinical trials of the Sanna Sleep formulation.

The trials will be designed and executed by industry leader Lindus Health. Protocol design, patient recruitment, data collection and delivery will be handled by their team of experts.

Reach Out to Sanna Science